Small Cell Lung Cancer - Immunotherapy: ASCO Tumor Boards

Product ID : SCLITB17
Price: $15.00
You will receive a link to your product from customerservice@asco.org within 1 hour of purchase confirmation. Shipping charges do not apply to digital products.
E-mail to a friend

Purchase

Description

This is a case-based activity that includes discussion of a 71-year-old male who presented to the clinic with significant weight loss, cough, significant bilateral upper limb weakness, and double vision. He is a heavy former smoker with a two pack-per-day history of 60 years. Work up includes a CT of the thorax and biopsy of the supraclavicular lymph node.

 

At the end of this course, learners should be able to:

• Discuss the diagnostic approach and landscape of therapeutic options for patients with advanced small cell lung cancer.

• Review the emerging actionable alterations and emerging targets in small cell lung cancer.

• Interpret the data related to PD-1 based immunotherapy in patients with advanced small cell lung cancer.

• Recognize potential clinical applications for PD-1 based immunotherapy and management of common side effects.

 

IMPORTANT NOTE: This course expires on March 22, 2020. Participants must complete all necessary course components by this date.

 

Purchase the 2017 ASCO Tumor Boards Bundle to access to all 2017 ASCO Tumor Boards for added savings. Purchased separately, these items would be $180 altogether. When bundled, you save $55.

Recommended Products